UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 478

Sortiert nach

Vaccine candidates against leishmania under current research

Expert review of vaccines, 2018-04, Vol.17 (4), p.323-334

2018

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models

PLoS neglected tropical diseases, 2017-05, Vol.11 (5), p.e0005644-e0005644

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer

Journal of cellular and molecular medicine, 2019-02, Vol.23 (2), p.934-942

2019

Link zum Volltext

Verfügbarkeit prüfen

Transcriptionally Driven DNA Replication Program of the Human Parasite Leishmania major

Cell reports (Cambridge), 2016-08, Vol.16 (6), p.1774-1786

2016

Link zum Volltext

Verfügbarkeit prüfen

Indotecan (LMP400) and AM13-55: Two Novel Indenoisoquinolines Show Potential for Treating Visceral Leishmaniasis

Antimicrobial Agents and Chemotherapy, 2012-10, Vol.56 (10), p.5264-5270

2012

Link zum Volltext

Verfügbarkeit prüfen

Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect

Biochemical pharmacology, 2013-05, Vol.85 (10), p.1433-1440

2013

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice

Vaccines (Basel), 2020-03, Vol.8 (1), p.141

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance

Korean Journal of Radiology, 2021, 22(4), , pp.559-567

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular Characterization of Tc964, A Novel Antigenic Protein from Trypanosoma cruzi

International journal of molecular sciences, 2020-03, Vol.21 (7), p.2432

2020

Link zum Volltext

Verfügbarkeit prüfen

Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis

PLoS neglected tropical diseases, 2012-11, Vol.6 (11), p.e1927-e1927

2012

Link zum Volltext

Verfügbarkeit prüfen

CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer

British journal of cancer, 2019-06, Vol.120 (12), p.1120-1128

2019

Link zum Volltext

Verfügbarkeit prüfen

A Single-Center Experience With Third and Fourth Kidney Transplants and Second Kidney Transplant After Pancreas-Kidney Transplant: Surgical Aspects and Outcomes

Experimental and clinical transplantation, 2020-04, Vol.18 (2), p.149-152

2020

Link zum Volltext

Verfügbarkeit prüfen

Inoculation of the Leishmania infantum HSP70-II Null Mutant Induces Long-Term Protection against L. amazonensis Infection in BALB/c Mice

Microorganisms (Basel), 2021-02, Vol.9 (2), p.363

2021

Link zum Volltext

Verfügbarkeit prüfen

A dataset of proteins associated with Trypanosoma cruzi LYT1 mRNAs

Data in brief, 2022-04, Vol.41, p.107953-107953, Article 107953

2022

Link zum Volltext

Verfügbarkeit prüfen

Trypanosoma cruzi Ikiakarora (TcIII) Draft Genome Sequence

Microbiology resource announcements, 2020-07, Vol.9 (27)

2020

Link zum Volltext

Verfügbarkeit prüfen

Proteins interacting with Leishmania major PUF1: A proteomic dataset

Data in brief, 2020-12, Vol.33, p.106594-106594, Article 106594

2020

Link zum Volltext

Verfügbarkeit prüfen

Extracorporeal shock wave lithotripsy for distal ureteral calculi: Improved efficacy using low frequency

International journal of urology, 2013-02, Vol.20 (2), p.214-219

2013

Link zum Volltext

Verfügbarkeit prüfen

Urinary bladder cancer risk factors in men: a Spanish case-control study

European journal of cancer prevention, 2006-12, Vol.15 (6), p.498

2006

Link zum Volltext

Verfügbarkeit prüfen

Impact of Rituximab-Based Therapy After Histological Transformation on High-Dose Therapy and Autologous Stem Cell Transplantation in Follicular Transformed Lymphomas

Blood, 2011-11, Vol.118 (21), p.4478-4478

2011

Link zum Volltext

Verfügbarkeit prüfen

Variability of the Pr77 sequence of L1Tc retrotransposon among six T. cruzi strains belonging to different discrete typing units (DTUs)

Acta tropica, 2021-10, Vol.222, p.106053-106053, Article 106053

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 478

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(437)
Mit Volltextzugriff
(447)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Vaccine candidates against leishmania under current research

Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study

Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer

Transcriptionally Driven DNA Replication Program of the Human Parasite Leishmania major

Indotecan (LMP400) and AM13-55: Two Novel Indenoisoquinolines Show Potential for Treating Visceral Leishmaniasis

Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect

Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance

Molecular Characterization of Tc964, A Novel Antigenic Protein from Trypanosoma cruzi

Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis

CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer

A Single-Center Experience With Third and Fourth Kidney Transplants and Second Kidney Transplant After Pancreas-Kidney Transplant: Surgical Aspects and Outcomes

Inoculation of the Leishmania infantum HSP70-II Null Mutant Induces Long-Term Protection against L. amazonensis Infection in BALB/c Mice

A dataset of proteins associated with Trypanosoma cruzi LYT1 mRNAs

Trypanosoma cruzi Ikiakarora (TcIII) Draft Genome Sequence

Proteins interacting with Leishmania major PUF1: A proteomic dataset

Extracorporeal shock wave lithotripsy for distal ureteral calculi: Improved efficacy using low frequency

Urinary bladder cancer risk factors in men: a Spanish case-control study

Outcomes of Chronic Myeloid Leukemia (CML) Patients Who Stopped Second Generation Tyrosine Kinase Inhibitors (2GTKIs) As Second Line Treatment. Results of the CML Spanish National Registry (RELMC)

Switching to a Second Generation TKI in Chronic Myeloid Leukemia Patients with Late Suboptimal Response with Imatinib Obtained Better Molecular Responses That the “Watch and Wait” Approach. an Experience of a Multicenter Registry in Patients Outside Clinical Trials

A Good Adherence to ELN 09 Recommendations in Chronic Myeloid Leukemia (CML) Treatment with Imatinib, Is Associated with Better Outcomes in Patients Treated Outside Clinical Trials

Impact of Rituximab-Based Therapy After Histological Transformation on High-Dose Therapy and Autologous Stem Cell Transplantation in Follicular Transformed Lymphomas

Switching to second‐generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib‐treated patients with chronic myeloid leukemia with more than 10% of BCR‐ABL/ABL ratio at 3 months

Variability of the Pr77 sequence of L1Tc retrotransposon among six T. cruzi strains belonging to different discrete typing units (DTUs)

Suchergebnisse filtern